About Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3
Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3 is a rare disease catalogued by Orphanet (ORPHA:62). It is associated with the SGCA gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3 trials.
Search ClinicalTrials.gov for "Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3" or filter by Orphanet code ORPHA:62 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3 trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3. Updated daily.